In agreement with prior studies, JAK2 mutation, prior CVD, and early post-MPN diagnosis have been associated with increased risks of arterial thrombosis in MPNs in prior studies [4,5,8,15]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.